Poster Session A
Juvenile idiopathic arthritis (JIA) and pediatric joint disorders
Hermine Brunner, MD, MSc, MBA
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
Disclosure(s): AbbVie: Consultant (Ongoing); AstraZeneca-Medimmune: Consultant (Ongoing); Biogen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb (BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Celgene: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); EMD Serono: Consultant (Ongoing); F-Hoffman La Roche: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein (GSK): Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon: Consultant (Ongoing), Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)